Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative bioavailability study comparing two tablet strengths with an oral solution in Parkinson's disease
NL-OMON59236Phase 1Completed
- Sponsor
- Arvinas
- Start
- Feb 2025
- Countries
- 1
01
Overview
Phase 1 trial in Parkinson's disease (PD) (3 arms), sponsored by Arvinas. Primary endpoint: Primary endpoint(s). Started Feb 2025; status: completed.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON59236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59236.